Parathion


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000014 Abnormalities, Drug-Induced PMID:161493
MESH:D000382 Agricultural Workers' Diseases PMID:11874814; PMID:17119214; PMID:17932376; PMID:19541724; PMID:20164001; PMID:22102698; PMID:23833127; PMID:24064777; PMID:24727735; PMID:24906048
MESH:D001249 Asthma PMID:17932376; PMID:19541724
MESH:D001943 Breast Neoplasms PMID:12762645
MESH:D002471 Cell Transformation, Neoplastic PMID:17622325
MESH:D003866 Depressive Disorder PMID:24906048
MESH:D003876 Dermatitis, Atopic PMID:21864637; PMID:22842586
MESH:D003920 Diabetes Mellitus PMID:24727735
MESH:D004409 Dyskinesia, Drug-Induced PMID:17707571
MESH:D007035 Hypothermia PMID:21767560; PMID:22986948; PMID:7150809
MESH:D007037 Hypothyroidism PMID:24064777
MESH:D007153 Immunologic Deficiency Syndromes PMID:6857660
MESH:D007154 Immune System Diseases PMID:22834942
MESH:D007248 Infertility, Male PMID:16029889
MESH:D007859 Learning Disabilities PMID:20015457; PMID:24291005
MESH:D008325 Mammary Neoplasms, Experimental PMID:11401758
MESH:D008545 Melanoma PMID:20164001
MESH:D008569 Memory Disorders PMID:20015457; PMID:22986948
MESH:D009069 Movement Disorders PMID:22986948
MESH:D011471 Prostatic Neoplasms PMID:22102698; PMID:23833127
MESH:D012135 Respiratory Sounds PMID:11874814; PMID:17119214
MESH:D012140 Respiratory Tract Diseases PMID:17119214
MESH:D012640 Seizures PMID:23085523
MESH:D014202 Tremor PMID:21767560
MESH:D015430 Weight Gain PMID:20123610
MESH:D015431 Weight Loss PMID:17707571; PMID:22986948; PMID:34813904
MESH:D016535 Bronchial Hyperreactivity PMID:23377347
MESH:D020820 Dyskinesias PMID:23933531
MESH:D047928 Premature Birth PMID:31675560
MESH:D062025 Organophosphate Poisoning PMID:17707571; PMID:18378376; PMID:6857660; PMID:7059232; PMID:7150809
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:20206647

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.